quinazolines has been researched along with Argentaffinoma in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bergmann, F; Breinig, M; Ehemann, V; Esposito, I; Fischer, L; Friess, H; Herpel, E; Höpfner, M; Kern, MA; Kleeff, J; Köhler, C; Rieker, RJ; Schirmacher, P | 1 |
| Aubry, MC; Rickman, OB; Sanyal, B; Thomas, CF; Vohra, PK; Vrana, JA; Wigle, DA | 1 |
| Georgieva, I; Grabowski, P; Holstein, J; Hopfenmüller, W; Koychev, D; Wang, Y; Zeitz, M | 1 |
| Kickler, TS; Lynch, DR; Rade, JJ | 1 |
| Gerst, B; Höpfner, M; Scherübl, H; Sutter, AP; Zeitz, M | 1 |
| Erickson, LA; Hobday, T; Jin, L; Leontovich, AA; Lloyd, RV; Ruebel, KH; Stilling, GA; Tanizaki, Y; Zhang, H; Zhang, S | 1 |
6 other study(ies) available for quinazolines and Argentaffinoma
| Article | Year |
|---|---|
Expression pattern and functional relevance of epidermal growth factor receptor and cyclooxygenase-2: novel chemotherapeutic targets in pancreatic endocrine tumors?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Apoptosis; Blotting, Western; Carcinoid Tumor; Celecoxib; Cell Line, Tumor; Cell Survival; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; ErbB Receptors; Female; Humans; Insulinoma; Male; Mice; Mice, Transgenic; Middle Aged; Pancreatic Neoplasms; Pyrazoles; Quinazolines; Sulfonamides; Tumor Cells, Cultured; Tyrphostins; Young Adult | 2009 |
Analysis of ErbB receptors in pulmonary carcinoid tumors.
Topics: Adult; Aged; Base Sequence; Carcinoid Tumor; Cell Proliferation; DNA Mutational Analysis; ErbB Receptors; Erlotinib Hydrochloride; Female; Humans; Immunoblotting; Immunohistochemistry; Lung Neoplasms; Male; Middle Aged; Mutation; Phosphorylation; Polymorphism, Single Nucleotide; Quinazolines; ras Proteins; Receptor, ErbB-2; Receptor, ErbB-3; Receptor, ErbB-4; Signal Transduction | 2009 |
ZM447439, a novel promising aurora kinase inhibitor, provokes antiproliferative and proapoptotic effects alone and in combination with bio- and chemotherapeutic agents in gastroenteropancreatic neuroendocrine tumor cell lines.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Hormonal; Apoptosis; Aurora Kinases; Benzamides; Carcinoid Tumor; Carcinoma, Neuroendocrine; Cell Division; Cell Line, Tumor; Cisplatin; Doxorubicin; Drug Interactions; Drug Therapy, Combination; Fluorouracil; Humans; Inhibitor of Apoptosis Proteins; Microtubule-Associated Proteins; Octreotide; Pancreatic Neoplasms; Protein Serine-Threonine Kinases; Quinazolines; Somatostatin; Streptozocin; Survivin; Synaptophysin | 2010 |
Recurrent myocardial infarction associated with gefitinib therapy.
Topics: Antineoplastic Agents; Carcinoid Tumor; Gefitinib; Humans; Male; Middle Aged; Myocardial Infarction; Neoplasm Metastasis; Quinazolines | 2011 |
A novel approach in the treatment of neuroendocrine gastrointestinal tumours. Targeting the epidermal growth factor receptor by gefitinib (ZD1839).
Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Carcinoid Tumor; Carcinoma, Neuroendocrine; Cell Cycle; Cell Line, Tumor; Dose-Response Relationship, Drug; ErbB Receptors; Fluorescent Antibody Technique; Gastrointestinal Neoplasms; Gefitinib; Gene Expression Regulation, Neoplastic; Humans; Insulinoma; Oligonucleotide Array Sequence Analysis; Pancreatic Neoplasms; Quinazolines; Reverse Transcriptase Polymerase Chain Reaction | 2003 |
Characterization of the functional and growth properties of cell lines established from ileal and rectal carcinoid tumors.
Topics: Adenoviridae; Antigens, Polyomavirus Transforming; Antineoplastic Agents; Apoptosis; Blotting, Western; Carcinoid Tumor; Cell Line, Tumor; Cell Proliferation; ErbB Receptors; Gefitinib; Gene Expression Profiling; Genetic Vectors; Humans; Ileal Neoplasms; Immunohistochemistry; Octreotide; Oligonucleotide Array Sequence Analysis; Quinazolines; Receptors, Calcitriol; Receptors, Somatostatin; Rectal Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; Transforming Growth Factors | 2007 |